AGILON HEALTH INC (AGL) Stock Price, Quote, News and Overview
NYSE:AGL - New York Stock Exchange, Inc. - US00857U1079 - Common Stock - Currency: USD
AGL Quote, Performance and Key Statistics
3.51
-0.02 (-0.57%)
The current stock price of AGL is 3.51 USD. In the past month the price increased by 7.01%. In the past year, price decreased by -40.71%.
AGL Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 11.74 | 87.86B | ||
| CVS | CVS HEALTH CORP | 12.24 | 83.63B | ||
| LH | LABCORP HOLDINGS INC | 17.37 | 21.18B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.46 | 19.48B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 15.78 | 14.07B | ||
| DVA | DAVITA INC | 15.48 | 11.76B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 115.35 | 11.05B | ||
| CHE | CHEMED CORP | 25.75 | 8.72B | ||
| HIMS | HIMS & HERS HEALTH INC | 66.57 | 7.99B | ||
| OPCH | OPTION CARE HEALTH INC | 27.88 | 5.62B | ||
| CRVL | CORVEL CORP | 26.02 | 5.59B | ||
| GH | GUARDANT HEALTH INC | N/A | 4.85B |
Related stock screener links
About AGL
Company Profile
Agilon Health, Inc. engages in providing healthcare services. The company is headquartered in Austin, Texas and currently employs 1,117 full-time employees. The company went IPO on 2021-04-15. The company enables primary care physicians (PCP) to be the agents for change in the communities they serve. Through its combination of the agilon platform, a long-term partnership model with existing physician groups and a growing network of like-minded physicians, it offers healthcare for seniors across communities throughout the United States. Its model operates by primarily forming risk-bearing entities (RBEs) within local geographies, that enter into arrangements with payors providing for monthly payments to manage the total healthcare needs of its physician partners’ attributed patients (or global capitation arrangements). The company focuses on community-based physician groups and is built around three key elements: agilon’s platform, agilon’s long-term physician partnership approach, and agilon’s network. The agilon platform is holistic in supporting the rapid transition to a Total Care Model with technology, people, process and capital.
Company Info
AGILON HEALTH INC
6210 E Hwy 290, Suite 450
Austin TEXAS US
CEO: Steve Sell
Employees: 1117
Company Website: https://www.agilonhealth.com/
Investor Relations: http://investors.agilonhealth.com/overview/default.aspx
Phone: 15622563800
AGILON HEALTH INC / AGL FAQ
What is the stock price of AGILON HEALTH INC today?
The current stock price of AGL is 3.51 USD. The price decreased by -0.57% in the last trading session.
What is the ticker symbol for AGILON HEALTH INC stock?
The exchange symbol of AGILON HEALTH INC is AGL and it is listed on the New York Stock Exchange, Inc. exchange.
On which exchange is AGL stock listed?
AGL stock is listed on the New York Stock Exchange, Inc. exchange.
What is the price forecast or stock price prediction for AGILON HEALTH INC stock?
27 analysts have analysed AGL and the average price target is 3.35 USD. This implies a price decrease of -4.65% is expected in the next year compared to the current price of 3.51. Check the AGILON HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AGILON HEALTH INC worth?
AGILON HEALTH INC (AGL) has a market capitalization of 1.45B USD. This makes AGL a Small Cap stock.
How many employees does AGILON HEALTH INC have?
AGILON HEALTH INC (AGL) currently has 1117 employees.
What are the support and resistance levels for AGILON HEALTH INC (AGL) stock?
AGILON HEALTH INC (AGL) has a support level at 3.11 and a resistance level at 3.59. Check the full technical report for a detailed analysis of AGL support and resistance levels.
Is AGILON HEALTH INC (AGL) expected to grow?
The Revenue of AGILON HEALTH INC (AGL) is expected to grow by 1.21% in the next year. Check the estimates tab for more information on the AGL EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AGILON HEALTH INC (AGL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AGL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AGL, evaluating the profitability, health, valuation and growth aspects
- AGILON HEALTH INC (AGL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AGILON HEALTH INC (AGL) Sales and EPS estimates to see what analysts future expectations are.
- AGILON HEALTH INC (AGL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AGILON HEALTH INC (AGL) Insider and Institutional Ownership to learn about the owners and their transactions.
- AGILON HEALTH INC (AGL) Stock Chart to make your own analysis
- AGILON HEALTH INC (AGL) Latest news and press-releases to stay up to date.
Does AGILON HEALTH INC (AGL) stock pay dividends?
AGL does not pay a dividend.
When does AGILON HEALTH INC (AGL) report earnings?
AGILON HEALTH INC (AGL) will report earnings on 2025-05-05, after the market close.
What is the Price/Earnings (PE) ratio of AGILON HEALTH INC (AGL)?
AGILON HEALTH INC (AGL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.63).
What is the Short Interest ratio of AGILON HEALTH INC (AGL) stock?
The outstanding short interest for AGILON HEALTH INC (AGL) is 6.07% of its float. Check the ownership tab for more information on the AGL short interest.
AGL Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to AGL. When comparing the yearly performance of all stocks, AGL is one of the better performing stocks in the market, outperforming 84.41% of all stocks.
AGL Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AGL. AGL may be in some trouble as it scores bad on both profitability and health.
AGL Financial Highlights
Over the last trailing twelve months AGL reported a non-GAAP Earnings per Share(EPS) of -0.63. The EPS decreased by -28.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15% | ||
| ROE | -55.24% | ||
| Debt/Equity | 0.07 |
AGL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 64% to AGL. The Buy consensus is the average rating of analysts ratings from 27 analysts.
For the next year, analysts expect an EPS growth of 35.94% and a revenue growth 1.21% for AGL